Proposed mechanisms for fibrointimal proliferation in pulmonary tumour thrombotic microangiopathy (PTTM). Proposed mechanisms for fibrointimal proliferation.

Slides:



Advertisements
Similar presentations
Dialogue Replaces Monologue:
Advertisements

Wound Healing Dr. Raid Jastania.
Pulmonary Tumor Thrombotic Microangiopathy R3 김형오.
Wound repair in healthy lungs and IPF
A) High-resolution computed tomography scanning (case 1, 14 days prior to death) showing widespread ground glass opacification, faint nodules, thickening.
Angiogenesis and hepatocellular carcinoma
Kusumawadee Utispan, Sittichai Koontongkaew 
Immune mediators of tissue remodelling and lung function impairment in tuberculosis. Immune mediators of tissue remodelling and lung function impairment.
Angiogenic properties of sustained release platelet-rich plasma: Characterization in-vitro and in the ischemic hind limb of the mouse  Shyamal Chandra.
Inducing Angiogenesis
Wound repair in healthy lungs and IPF
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Extracellular Vesicles in Cancer: Cell-to-Cell Mediators of Metastasis
Figure 1 Mechanisms of metastatic growth in the heart
S. S. Pullamsetti, R. Savai, W. Janssen, B. K. Dahal, W. Seeger, F
Management of advanced renal cancer
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Volume 56, Issue 3, Pages (March 2012)
Volume 18, Issue 4, Pages (October 2013)
Nat. Rev. Urol. doi: /nrurol
Figure 1 Overview of the immunopathogenesis of ulcerative colitis
Nat. Rev. Rheumatol. doi: /nrrheum
Figure 1 The coagulation system
Nat. Rev. Nephrol. doi: /nrneph
Nat. Rev. Clin. Oncol. doi: /nrclinonc
Angiogenesis and hepatocellular carcinoma
Alveolar lymphangiogenesis is a feature of idiopathic pulmonary fibrosis (IPF). a) Tissue sections reacted with anti-D2-40 (brown) and anti-CD34 (red)
Volume 18, Issue 4, Pages (October 2013)
Vascular frontiers without borders
Thrombosis and Inflammatory Bowel Disease
Figure 2 The hypoxia-induced proinflammatory
ID Proteins Regulate Diverse Aspects of Cancer Progression and Provide Novel Therapeutic Opportunities  Radhika Nair, Wee Siang Teo, Vivek Mittal, Alexander.
The key pathological mechanisms underlying vascular changes in pulmonary hypertension (PH). The key pathological mechanisms underlying vascular changes.
Key functions of innate lymphoid cells in resolution of inflammation in asthma. a) Natural killer (NK) cells and b) type 2 innate lymphoid cells (ILC2s)
Correction Journal of Vascular Surgery
Process and mechanisms of blood vessel formation.
Tumor-Associated Macrophages: From Mechanisms to Therapy
The mechanisms by which mitochondrial dysfunction in chronic obstructive pulmonary disease (COPD) lead to increased oxidative stress and inflammation,
Inflammatory responses elicited by e-liquid vaping.
Romain Gallet et al. BTS 2016;1:14-28
Pathogenesis of idiopathic pulmonary fibrosis (IPF).
Immune reconstitution inflammatory syndrome (IRIS) associated with Mycobacterium tuberculosis (TB) infection. a) In healthy individuals in response to.
CD4+ T cells: a potential player in renal fibrosis
The VEGF Family, the Inside Story
The antifibrotic activity of pirfenidone in preclinical models of pulmonary fibrosis. a) Experimental design and effects of prophylactic pirfenidone treatment.
Schematic illustration of the concepts in the pathogenesis of rheumatoid arthritis associated-interstitial lung disease (RA-ILD). Schematic illustration.
Molecular factors involved in pulmonary fibrosis in fra-2tg mice.
Post-ischemic vascular repair mechanisms and the growth factors involved. Post-ischemic vascular repair mechanisms and the growth factors involved. The.
Pulmonary cytokine expression in C57Bl/6 mice post IT-LPS.
Mechanism of PD-1/PD-L1 pathway-induced immunosuppression within the tumour microenvironment. Mechanism of PD-1/PD-L1 pathway-induced immunosuppression.
Mechanisms of virus-induced airway inflammation in chronic obstructive pulmonary disease (COPD). Mechanisms of virus-induced airway inflammation in chronic.
Established and putative mediators and pathways involved in the pathogenesis of pulmonary arterial hypertension. Established and putative mediators and.
Takamune Takahashi, Uyen Huynh-Do, Thomas O. Daniel 
Endobronchial biopsy from case 2 showing sheets of epitheloid macrophages without giant cells, mixed with other chronic inflammatory cells. Endobronchial.
Vallerie V. McLaughlin et al. JACC 2015;65:
Molecular pathways underlying angiogenesis.
Protease/anti-protease imbalance and oxidative stress are viable pro-inflammatory mechanisms that contribute to the pathogenesis of chronic obstructive.
A) Small pulmonary arteries within a fibrotic area (usual interstitial pneumonia lung). a) Small pulmonary arteries within a fibrotic area (usual interstitial.
Nat. Rev. Rheumatol. doi: /nrrheum
Lung histology from a case of pulmonary tumour thrombotic microangiopathy related to severe pulmonary hypertension. a) Post mortem section showing occlusion.
Compounds acting on pathogenic pathways of pulmonary arterial hypertension. Compounds acting on pathogenic pathways of pulmonary arterial hypertension.
Figure 1. Initiation of vasculitic lesions in small vessels by ANCA-activating cytokine-primed neutrophils in the wrong place and at the wrong time. Figure.
Overview of important signalling pathways in angiogenesis and antiangiogenic agents. Overview of important signalling pathways in angiogenesis and antiangiogenic.
Lymphatic vessels, inflammation, and immunity.
Cellular players and molecules in idiopathic pulmonary fibrosis (IPF) and systemic sclerosis-associated interstitial lung disease. Cellular players and.
Pathogenic concepts of pulmonary arterial hypertension (PAH).
Schematic of the relationship between smoking and legume consumption (smoking–diet relationship) in relation to pulmonary inflammation, systemic inflammation,
Vascular frontiers without borders
Schematic diagram of the potential cellular effects of interleukin (IL)-4/IL-13 on inflammatory and structural cells in asthma. Schematic diagram of the.
Effect of placebo (n=88) and bosentan (n=80) on the co-primary end-point pulmonary vascular resistance (PVR) in the EARLY (Endothelial Antagonist Trial.
Presentation transcript:

Proposed mechanisms for fibrointimal proliferation in pulmonary tumour thrombotic microangiopathy (PTTM). Proposed mechanisms for fibrointimal proliferation in pulmonary tumour thrombotic microangiopathy (PTTM). Small nests of carcinomatous cells lodge in the pulmonary vessels, including small pre-capillary arteries (via haematogenous spread) and on the post-capillary side of the pulmonary circulation to pulmonary veins and lymphatics (by lymphatic invasion). Tumour cell and endothelial cell interaction initiates clot formation, and releases further cytokines including vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF). This initiates macrophage recruitment and intimal (endothelial cell and non-endothelial cell like, i.e. myofibroblastic) proliferation. Tissue factor also upregulates VEGF expression on tumour cells, which is angiogenic to intimal cells. PDGF-A and -B are expressed on tumour cells, and anti-phospho-PDGFR-α is expressed on vascular endothelial cell and gastric carcinoma cells. This indicates that PDGF signalling activation of tumour cell growth is present through both autocrine and paracrine mechanisms. The cytokine and adhesive protein osteopontin is expressed on tumour cells in PTTM, and is likely to be a key driver for intimal cell growth. Perivascular CD68-positive macrophages are noted and also reside within intimal layers. Macrophages also stain for CD44, the adhesion molecule which interacts with osteopontin to induce chemotaxis of T-cells and macrophages, propagation of local inflammation and intimal proliferation (through other known macrophage-derived pro-proliferative factors including interleukin (IL)-6). Direct contact with tumour nests is not universal in all vessels where remodelling is present. Laura C. Price et al. Eur Respir Rev 2019;28:180065 ©2019 by European Respiratory Society